SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-040437
Filing Date
2020-03-30
Accepted
2020-03-30 16:52:05
Documents
1
Group Members
RAY PRUDO, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2014247d1_sc13da.htm SC 13D/A 47591
  Complete submission text file 0001104659-20-040437.txt   49372
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13D/A | Act: 34 | File No.: 005-87614 | Film No.: 20757838
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O LANDMARK FIDUCIAIRE (SUISSE) SA 6 PLACE DES EAUX-VIVES, PO BOX 3461 GENEVA V8 1211
Business Address C/O LANDMARK FIDUCIAIRE (SUISSE) SA 6 PLACE DES EAUX-VIVES, PO BOX 3461 GENEVA V8 1211 44 (0)20 7025 7911
RPC Pharma Ltd (Filed by) CIK: 0001653315 (see all company filings)

IRS No.: 000000000 | State of Incorp.: IL
Type: SC 13D/A